Abstract: Spa therapy represents a popular treatment for many rheumatic diseases. The mechanisms by which immersion in mineral or thermal water or the application of mud alleviates suffering in rheumatic diseases are not fully understood. The net benefit is probably the result of a combination of factors, with mechanical, thermal, and chemical effects among the most prominent ones. Buoyancy, immersion, resistance, and temperature all play imessentialoles. According to the gate theory, pain relief may be due to the pressure and temperature of the water on the skin; hot stimuli may influence muscle tone and pain intensity, helping to reduce muscle spasm and to increase the pain threshold. Mud-bath therapy increases plasma b-endorphin levels and secretion of corticotrophin, cortisol, growth hormone, and prolactin. It has recently been demonstrated that thermal mud-pack treatment induces a reduction in the circulating levels of prostaglandin E2 (PGE2), leukotriene B4 (LTB4), interleukin-1b (IL-1b) and tumor necrosis factor-a (TNF-a), important mediators of inflammation and pain. Spa therapy has been found to cause an increase in insulin-like growth factor-1 (IGF1), which stimulates cartilage metabolism, and transforming growth factor-b (TGF-b). There is also evidence of the affirmative action of mud-packs and thermal baths on the oxidant/ the antioxidant system, with a reduction in the release of reactive oxygen (ROS) and nitrogen (RNS) species. Overall, thermal stress has an immunosuppressive effect. Many other non-specific factors may also contribute to the beneficial effects observed after spa therapy in some
rheumatic diseases, including effects on cardiovascular risk
factors, and changes in the environment, pleasant surroundings and the absence of work duties.
Spa therapy comprises a broad spectrum of therapeutic modalities, including hydrotherapy, balneotherapy, physiotherapy, mud-pack therapy, and exercise [1, 2]. This therapeutic approach has been successfully used in many European countries, as well as in Japan and Israel, in classical medicine as a cure for various illnesses. Today, it continues to be a popular treatment for many rheumatic diseases (RD) [3] due to their chronic nature, problems related to the use of drugs that often have significant side effects and the occasional lack of valid therapeutic strategies [4–8]. Thousands of years of history and the abundance of spa resorts in many European countries have undoubtedly contributed to the popularity of these therapies. Spa therapy aims to reduce pain, relieve muscle spasms and improve muscle strength and functional mobility [1, 2]. Nevertheless, despite their long history and popularity, spa treatments are still the subject of debate and their role in modern medicine continues to be unclear [9].
The action mechanisms of mud-packs and thermal baths are not fully known, and it is difficult to distinguish the effects of thermal applications from the benefits that could be derived from a stay in a spa environment [1].
In an era of evidence-based medicine, it is necessary to ask what real medical and scientific value these therapies have. The objective of this review is to summarize the currently available information on mechanisms of action and possible effects of spa therapy in RD. We also provide some suggestions for further development in this area.
The mechanisms by which immersion in thermal mineral water or the application of mud packs alleviate suffering in RD are not fully understood. The net benefit is probably the result of a combination of factors, with mechanical, thermal and chemical effects among the most prominent ones [1]. A distinction can be made between the non-specific (hydrotherapeutic in a broad sense) mechanisms common to simple baths in hot tap water and specific (hydromineral and chemotherapeutic) mechanisms, which depend on the chemical and physical properties of the water used. While the former are well known, the latter are difficult to identify and assess [1].
Spa therapy may have beneficial effects on muscle tone, joint mobility and pain intensity. Increased buoyancy and hydrostatic pressure during immersion in thermal mineral water cause many physiological changes. Immersion to the suprasternal notch in spa water (35C) results in a cascade of reactions including increased diuresis, natriuresis and cardiac output [10–12]. The basis of these physiological effects is considered to be hydrostatic pressure, which forces approximately 700 ml from the lower extremities to the central compartment. Distension of volume receptors by this central hypervolemia is regarded as the trigger for the observed physiological effects [10–12]
The effects of mud-packs and thermal baths are partially related to temperature. Thermal stimuli may influence muscle tone and pain intensity, helping to reduce muscle spasm and to increase the pain threshold in nerve endings. According to the ‘‘gate theory’’, pain relief may be due to the temperature and hydrostatic pressure of water on the skin [13]. Thermal stress provokes a series of neuroendocrine reactions. In particular, the heat stimulates the release of adrenocorticotropic hormone (ACTH), cortisol, prolactin., and growth hormone (GH), although it does not alter the circadian rhythm of these hormones [14]. The effect of thermal stress on the hypothalamus-pituitary-adrenal axis seems to be particularly crucial for the anti-edemigenous and anti-inflammatory actions of corticosteroids, as well as for the frequent alteration of the axis during some rheumatic diseases [15]. The increase in beta-endorphin demonstrated to occur with various spa therapy techniques [16–19] has an analgesic and antispastic effect that is particularly important in patients for whom pain is the prevalent symptom. Interestingly, it has been revealed that the application of mature thermal mud in healthy individuals brings about a rapid increase in plasma beta-endorphin, which returns to pre-treatment levels within the period of so-called thermal reaction [19]. This increase in beta-endorphin is probably the key factor in the mechanism of individual tolerance to thermal mud baths. Recent data have demonstrated the possibility that normal keratinocytes can produce and secrete a precursor proopiomelanocortin (POMC) following various stimuli (e.g. ultraviolet rays, thermal stimuli) which is the common precursor of various endorphins [20]. This finding allows us to formulate the fascinating hypothesis that ultraviolet radiation or thermal stimuli could be used to condition the skin’s production of opioid peptides, thus altering the personal emotional sphere or pain threshold. If we add that ß-endorphin also has immunomodulatory effects [21], the hypothesis of a close correlation between spa therapies and the psychoneuroendocrine system becomes increasingly convincing. Furthermore, hyperthermia plays an important role in immune system function. Hyperthermia also has many effects on granulocytes. Heat increases their mobility, phagocytic and bactericidal properties and enzymatic activity [1]. Furthermore, thermal stimulation increases the extensibility of collagen-rich tissues, such as tendons, fasciae and articular capsules, which may improve the range of motion of joints [1]. The effects described make it possible to break the vicious circle of pain–muscle contraction–altered joint dynamics–pain that characterizes many chronic arthropathies. The reduction in muscle tone and better use of joints represent just two of the most important elements that show the medium- and long-term beneficial effects documented in various clinical studies [22–31].
The chemical effects of mud packs and balneotherapy are less precise than the physical effects. In theory, it cannot be excluded that the organic substances or minerals in the water or mud, sometimes present in trace amounts, can be absorbed through the skin and then act at a systemic level. However, experimental evidence available in this field is scarce. Shani et al. [32] documented a significant increase in serum concentrations of bromine, rubidium, calcium and zinc in patients with psoriatic arthritis who bathed in the Dead Sea. Solute penetration is presumably influenced by the length of bathing time, the temperature of the thermal water, its composition, and other factors, some of which may still be unknown. An in vitro study has demonstrated that substances in aqueous mud extracts can permeate through human full-thickness skin in quantities that have definite effects on the spontaneous contractile activity of smooth muscle tissue [33]. Furthermore, it has been reported that the direct application of mud pack has greater clinical outcomes than the use of nylon-covered mud pack in patients with knee osteoarthritis (OA) [34]. This finding implies a contribution of the chemical properties of the dirt to the overall beneficial effects of mud-pack treatment, thus ruling out that the results are linked exclusively to the action of heat.
Since sulfur spa baths have been successfully used in various skin immuno-mediated afflictions, it has been suggested that absorption through the skin of trace elements present in mineral water and mud packs may affect the immune system [35]. Overall, thermal stress has an immunosuppressive effect. Concerning hyperthermia, a stimulatory effect of the immune response appears to prevail at a moderate increase in local skin temperature, with increases in the proinflammatory cytokines interleukin (IL)-6 [36] and IL-1ß [37], whereas higher temperatures (40–41C) apparently suppress immune functions [38, 39]. A significant reduction in the circulating levels of T lymphocytes have been demonstrated in healthy volunteers treated with hyperthermal baths [1] and in patients with respiratory and cutaneous atopy [40]. Hyperthermia induced T lymphocytopenia and eosinopenia may result from a redistribution of the cells, probably due to the increase in ACTH and cortisol provoked by thermal stress [14]. In vitro studies have demonstrated that sulfurous spa waters have a dose-dependent inhibitory effect on the blast transformation and proliferation of T lymphocytes obtained from peripheral blood in both healthy subjects and subjects affected by chronic inflammatory diseases [40]. On the other hand, immersion in thermal waters at a temperature of 40C reduces the lymphocyte response to phytohaemoagglutinin [41]. Sulfurous spa waters also seem to exert an intense inhibitory action on the production of cytokines, especially IL-2 and interferon-gamma (IFN-c). As Does CD4 mainly produce these cytokines? Lymphocytes, it can be hypothesized that memory T cells are the principal target of sulfur-rich waters. The application of sulfurous streams reduces the capacity of memory T cells to proliferate and produce cytokines, thus resulting in an alteration of the immune response [42]. Hyperthermia-induced modification of the cytokine milieu has been recently confirmed in patients affected by ankylosing spondylitis (AS) [43]. Tarner et al. showed that the serum levels of tumor necrosis factor (TNF)-a, IL-1b, and IL-6, which were measured before, during, and after whole-body hyperthermia, were significantly reduced in patients with AS. In contrast, the changes in healthy subjects were not statistically significant.
Recent studies have shown a reduction in the circulating levels of prostaglandin E2 (PGE2) and leukotriene B4 (LTB4), important mediators of inflammation and pain, in patients suffering from OA or fibromyalgia who undergo mud packs or balneotherapy [44, 45] (Table 1). Crenotherapy also affects the synthesis of various cytokines involved in the ongoing chondrolysis and inflammation in RD; in fact, a reduction in the cytokines IL-1ß and TNF-a and the soluble receptors of the latter has been demonstrated following a cycle of mud-bath therapy (temperature [41C) in patients with OA [46–48] (Table 1). Several studies have provided evidence for a significant role of matrix metalloproteinases (MMPs), particularly MMP-3 or stromelysin-1, produced by activated chondrocytes and other cell types in the development of cartilage degradation in joint diseases [49, 50]. A recent study by Bellometti et al. [51] showed that MMP-3 serum levels were significantly reduced by mud-bath therapy in patients with OA. Cycles of mud applications and balneotherapy also bring about an increase in some growth factors, such as insulin-like growth factor 1 (IGF1) [47], which stimulates cartilage anabolism [52]. Furthermore, a significant increase in the circulating levels of transforming growth factor-beta (TGF-ß) has been found in patients with AS after combined spa-exercise therapy (exercise, hyperthermia, and exposure to low doses of radon) [53] (Table 1). TGF-ß is a very potent immunomodulating and anti-inflammatory cytokine which plays a major role in tissue healing, bone remodeling, and fibrosis [54, 55]. Among the various factors responsible for inflammatory and degenerative phenomena in joints in various forms of RD, reactive oxygen species (ROS) and nitric oxide (NO) should be taken into consideration [56, 57]. Sulfurous waters have been demonstrated to have an the antioxidant effect in vitro; in fact, the incubation in sulfurous mineral water significantly reduces the release of ROS and the reactive nitrogen species (RNS) peroxynitrite by polymorphonucleate leukocytes (PMNs) stimulated by N-formyl-methionyl-leucyl-phenylalanine and phorbol-12- myristate-13-acetate [58]. Various studies in humans have highlighted the positive action of mud packs and thermal baths, especially sulfurous ones, on the oxidant/antioxidant system. Grabski et al. [59] reported the reduction in superoxide dismutase (SOD) activity in patients with rheumatoid arthritis (RA) undergoing treatment with sulphuric water. Eckmekcioglu et al. [60] demonstrated that 3 weeks of sulfur baths can reduce the antioxidative defense system (SOD and glutathione (GSH) peroxidase) in the blood of patients with OA. They suggested two possible causes for the decline of these enzyme activities: either as a consequence of reduced oxidative stress during sulfur therapy leading to a lower expression of these enzymes or as an enhanced generation of superoxide radicals were exhausting the superoxide-scavenging enzyme. Bender et al. [61] demonstrated that therapeutic baths in mineral water reduced the activity of catalase, SOD, malondialdehyde (MDA), and GSH peroxidase. Other authors have observed a significant decrease in NO and myeloperoxidase (MPO) and a slight increase in GSH peroxidase in the sera of subjects with OA undergoing cycles of mud applications and balneotherapy [62]. The slight increase in GSH peroxidase does not correlate with the reduction in the other biochemical markers, suggesting that thermal mud possesses different mechanisms of action. In a recent study, we assessed the possible modifications of plasma levels of leptin and adiponectin in patients with OA treated with a cycle of spa therapy [63]. Our data showed a slight but not significant increase in plasma leptin concentrations and a significant decrease in serum adiponectin levels at the end of the mud-bath therapy cycle. These adipocytokines play an important role in the pathophysiology of OA [64, 65]. In particular, there is some evidence that adiponectin in skeletal joints may have proinflammatory effects and may be involved in cartilage degradation [64, 66]. Because of these recent findings, the decrease in adiponectin after spa therapy demonstrated in our study may play a protective role in OA. Experimental studies in animal models of arthritis corroborate the evidence of beneficial effects of mud-bath therapy on inflammatory and degenerative joint diseases. Cozzi et al. [67] have recently demonstrated an antiinflammatory effect of mud-bath applications in Freund’s adjuvant-induced arthritis in rats. Following the application of crenotherapy, a reduction in edema in the rat paws (measured by plethysmometry) was accompanied by a significant decrease in the levels of circulating TNF-a and IL-1b. In 2007, Britschka et al. [68] confirmed the antiinflammatory and chondroprotective effects of the application of mud in Zymosan-induced arthritis in rats, by performing histological analysis on synovial tissues and cartilage is taken from the sacrificed animals on day 21 of treatment. Examination of the synovial membrane in particular revealed reduced hyperplasia of the lining, reduced vascularization and cellular infiltration in the group of rats treated with mud applications, in contrast to the group of rats treated with heated tap water and the untreated (control) group of rats. Concerning cartilage, there was a macroscopically visible reduction in erosive lesions as well as an increase in chondrocyte density and collagen and proteoglycan content only in the mud-treated animals (Figs. 1, 2).
Many other non-specific factors may also contribute to the beneficial effects observed after spa therapy in some RDs, including effects on cardiovascular risk factors. The lipid-normalizing effects of mud applications and balneotherapy, especially with sulfurous waters, have been reported for decades. The results of such research have documented reductions in total cholesterol, triglycerides and non-esterified cholesterol and a significant increase in HDL cholesterol [69, 70]. More recently, attention has focused on plasma homocysteine, a risk factor for coronary heart disease, congestive heart failure, systolic hypertension, atherothrombotic events, complications in diabetes mellitus, cancer and oxidative stress [71–75]. A significant reduction in plasma homocysteine has been demonstrated in OA patients after a cycle of sulfurous thermal baths [76]. Recently Ola´h et al. [77] explored changes in diverse cardiovascular risk factors in a group of patients suffering from degenerative musculoskeletal disorders subjected to a cycle of balneotherapy. The authors showed a statistically significant and lasting (3 months after the sequence of balneotherapy) decrease in serum levels of C-reactive protein (CRP) in patients treated with mineral thermal baths. The reduction in cardiovascular risk factors through the use of mud packs and balneotherapy is especially important considering the clear and much-stressed association between various RDs and atherosclerotic processes [78]. Finally, other elements need to be taken into consideration concerning the mechanisms of action of mud applications and balneotherapy in RD, such as the particular climatic and environmental conditions of spas and the fact that people rest more and are far from daily stress during stays at spa resorts [1, 2].
Although the data presented are stimulating, it is impossible to ignore the existence of a complex series of problems and uncertainties that prevent spa therapies from gaining the full consensus of the scientific community [9]. One of the critical points is the controversial problem of the absorption of the minerals dissolved in thermal waters, i.e. the demonstration of specific effects other than those linked to the simple action of heat. Unfortunately, few studies have been conducted on this topic, and little is known about the specific facts of various mineral waters. It is still not clear which elements are essential and what the ideal concentration of each component is to attain an optimal response to treatment. It remains to be clarified which mineral waters are most suitable for various diseases and whether the different parts exert specific actions. Such evidence would lead to a specialization of spa resorts, which could finally target their therapies more accurately and rationally.
In this review, we have underlined the effects of mud applications and balneotherapy on various mediators or factors of the immune response, inflammation, and chondrolysis. However, the results reported only refer to short-term modifications of these factors, lasting until the end of the cycle and little is known of the possible long-term effects. This is a crucial element in seeking to explain the persistence of the symptomatic benefit induced by such therapies in some RDs, as shown in long-term controlled clinical trials [22–31]. The evidence gained is therefore essential but only preliminary and awaits confirmation by more in-depth studies conducted according to the canons of modern scientific research. To develop Thermal Medicine as a valid and recognized field, a series of studies aimed at providing more precise therapeutic indications ever and clarifying the mechanisms of action and the effects deriving from the application of thermal treatments are imperative. This is the only way for Thermal Medicine to emerge from the restrictive environment of alternative or ‘‘miracle’’ therapies and free itself of the skepticism of many doctors and patients, gaining the scientific respect that it truly deserves.
Mechanisms of action of spa therapies in rheumatic diseases: What scientific
evidence is there?
Article in Rheumatology International · December 2010
DOI: 10.1007/s00296-010-1628-6 · Source: PubMed
Rheumatology International
Clinical and Experimental
Investigations
ISSN 0172-8172
Volume 31
Number 1
Rheumatol Int (2010) 31:1-8
DOI 10.1007/
s00296-010-1628-6
Rheumatol Int (2011) 31:1–8
DOI 10.1007/s00296-010-1628-6
REVIEW ARTICLE
Antonella Fioravanti • Luca Cantarini •
Giacomo Maria Guidelli • Mauro Galeazzi
Received: 7 April 2010 / Accepted: 13 November 2010 / Published online: 1 December 2010
Springer-Verlag 2010
1. Sukenik S, Flusser D, Abu-Shakra M (1999) The role of SPA therapy in various rheumatic diseases. Rheum Dis North Am 25:883–897
2. Bender T, Karagu¨lle Z, Ba`lint GP, Gutenbrunner C, Ba`lint PV, Sukenik S (2005) Hydrotherapy, balneotherapy, and spa treatment in pain management. Rheumatol Int 25:220–224
3. Nicholas JJ (1994) Physical modalities in rheumatological rehabilitation. Arch Phys Med Rehabil 75:994–1001
4. Ofman JJ, Maclean CH, Straus WL, Morton SC, Berger ML,
Roth EA et al (2002) A meta-analysis of severe upper gastrointestinal complications of nonsteroidal anti-inflammatory drugs.
J Rheumatol 29:804–812
5. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B,
Horgan K et al (2005) Trial investigations: cardiovascular events
associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092–1102
6. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR,
Patrono C (2006) Do selective cyclo-oxygenase-2 inhibitors and
traditional non-steroidal anti-inflammatory drugs increase the risk
of atherothrombosis? Meta-analysis of randomised trials. BMJ
332:1302–1308
7. Zhang W, Jones A, Doherty M (2004) Does paracetamol
(acetaminophen) reduce the pain of osteoarthritis?: a metaanalysis of randomised controlled trials. Ann Rheum Dis
63:901–907
8. Pincus T, Wang X, Chung C, Sokka T, Koch GG (2005) Patient
preference in a crossover clinical trial of patients with osteoarthritis of the knee or hip: face validity of self-report questionnaire
ratings. J Rheumatol 32:533–539
9. Verhagen AP, Bierma-Zeinstra SMA, Boers M et al (2007)
Balneotherapy for osteoarthritis. Cochrane database of systemic
reviews Issue 4. Art. No: CD006864. doi:10.1002/14651858
10. O’Hare JP, Heywood A, Summerhayes C et al (1985) Observation on the effects of the immersion in bath spa water. Br Med J
291:1747–1751
11. Weston CFM, O’Hare JP, Evans JM, Corral RJM (1987) Haemodynamic changes in man during immersion in water at different temperatures. Clin Sci 73:613–616
12. Epstein M (1992) Renal effects of head-out water immersion in
humans: a 15 year update. Physiol Rev 72:563–621
13. Melzack R, Wall PD (1965) Pain mechanism: a new theory.
Science 150:971–979
14. Kuczera M, Kokot F (1996) The influence of SPA therapy on
endocrine system. Stress reaction hormones. Pol Arch Med
Wewn 95:11–20
15. Gur A, Cevik R, Sarac AJ, Colpan L, Em S (2004) Hypothalamicpituitary-gonadal axis and cortisol in young women with primary
fibromyalgia: the potential roles of depression, fatigue, and sleep
disturbance in the occurrence of hypocortisolism. Ann Rheum
Dis 63:1504–1506
16. Laatikainen T, Salminen K, Kohvakka A, Pettersson J (1988)
Response of plasma endorphins, prolactin and catecholamines in
women to intense heat in a sauna. Eur J Appl Physiol Occup
Physiol 57:98–102
17. Vescovi PP, Gerra G, Pioli G, Pedrazzoni M, Maninetti L, Passeri
M (1990) Circulating opioid peptides during thermal stress. Horm
Metab Res 22:44–46
18. Kubota K, Kukabayashi H, Tamura K, Kawada E, Tamura J,
Shirakura T (1992) A transient rise in plasma b-endorphin after a
traditional 47C hot-spring bath in Kusatsu-spa, Japan. Life Sci
51:1877–1901
19. Cozzi F, Lazzarin I, Todesco S, Cima L (1995) Hypotalamic
pituary-adrenal axis dysregulation in healthy subjects undergoing
mud-bath-applications. Arthritis Rheum 38:724–725
20. Ghersetich I, Freedman D, Lotti T (2000) Balneology today.
JEADV 14:346–348
21. Berczi I, Chalmers IM, Nagy E, Warrington RJ (1996) The
immune effects of neuropeptides. Baillieres Clin Rheumatol
10:227–257
22. Guillemin F, Constant F, Collin JF, Boulange M (1994) Short and
long-term effect of Spa therapy in chronic low back pain. Br J
Rheumatol 33:148–151
23. Nguyen M, Revel M, Dougados M (1997) Prolonged effects of 3
weeks therapy in a Spa resort on lumbar spine, knee and hip
osteoarthritis: follow up after 6 months. A randomized controlled
trial. Br J Rheumatol 36:77–81
24. Elkayam O, Ophir J, Brener S, Paran D, Wigler I, Efron D et al
(2000) Immediate and delayed effects of treatment at the Dead
Sea in patients with psoriasis arthritis. Rheumatol Int 19:77–82
25. van Tubergen A, Landewe´ R, van der Hetijede D, Hidding A,
Walter N, Asscher M et al (2001) Combined Spa-Exercise
therapy is effective in patients with ankylosing spondylitis: a
randomized controlled trial. Arthritis Care Res 45:430–438
26. Cantarini L, Leo G, Giannitti C, Cevenini G, Barberini P,
Fioravanti A (2007) Therapeutic effect of spa therapy and short
wave therapy in knee osteoarthritis: a randomized, single blind,
controlled trial. Rheumatol Int 27:523–529
27. Fioravanti A, Perpignano G, Tirri G, Cardinale G, Giannitti C,
Lanza CE et al (2007) Effects of mud-bath treatment on fibromyalgia patients: a randomized clinical trial. Rheumatol Int
27:1157–1161
28. Karagu¨lle M, Karagu¨lle MZ, Karagu¨lle O, Do¨nmez A, Turan M
(2007) A 10- day course of spa therapy is beneficial for people
with severe knee osteoarthritis. Clin Rheumatol 26:2063–2071
29. Harzy T, Ghani N, Akasbi N, Bono W, Nejjari C (2009) Shortand long-term therapeutic effects of thermal mineral waters in
knee osteoarthritis: a systematic review of randomized controlled
trials. Clin Rheumatol 28:501–507
30. Forestier R, Desfour H, Tessier J-M, Franc¸on A, Foote AM,
Genty C et al (2009) Spa therapy in the treatment of knee
osteoarthritis, a large randomised multicentre trial. Ann Rheum
Dis 69:660–665
31. Fioravanti A, Iacoponi F, Bellisai B, Cantarini L, Galeazzi M
(2010) Short and long-term effect of spa therapy in knee osteoarthritis. Am J Phys Med Rehabil 89:125–132
32. Shani J, Barak S, Levi D, Ram M, Schachner ER, Schlesinger T
et al (1985) Skin penetration of minerals in psoriatics and
guinea pigs bathing in hypertonic salt solutions. Pharmacol Res
17:501–506
33. Beer AM, Junginger HE, Lukanov J, Sagorchev P (2003) Evaluation of the permeation of peat substances through human skin
in vitro. Int J Pharm 253:169–175
34. Odabasi E, Turan M, Erdem H, Tekbas F (2008) Does mud pack
treatment have any clinical effect? A randomized controlled
clinical study. J Altern Complement Med 14:559–565
35. Sukenik S, Abu-Shakra M, Flusser D (1997) Balneotherapy in
autoimmune diseases. Isr J Med Sci 33:258–261
36. Sobieska M, Stratz T, Samborski W, Hrycaj P, Mennet P, Mu¨ller
W (1993) Interleukin-6 (IL-6) after whole body cryotherapy and
local hot mud pack treatment. Eur J Phys Med Rehabil 3:205
37. Olszewski WL, Grzelak I, Ziolkowska A, Engeset A (1989)
Effect of local hyperthermia on lymph immune cells and lymphokines of normal human skin. J Surg Oncol 41:109–116
38. Schmidt KL, Simon E (2001) Thermotherapy of pain, trauma and
inflammatory and degenerative rheumatic diseases. Thermotherapy for Neoplasia, Inflammation and Pain. Springer, Berlin,
pp 527–539
39. Lange U, Mu¨ller-Ladner U, Schmidt KL (2006) Balneotherapy in
rheumatic diseases-an overview of novel and known aspects.
Rheumatol Int 26:497–499
40. Valitutti S, Costellino F, Musiani P (1990) Effect of sulfurous
(thermal) water on T lymphocyte proliferative response. Ann
Allergy 65:463–468
41. Smith JB, Knowlton RP, Agarwal SS (1978) Human lymphocyte
responses are enhanced by culture at 40C. J Immunol
121:691–696
42. Ghersetic I, Lotti T (1996) Immunologic aspects: immunology of
mineral waters. Clin Dermatol 14:563–566
43. Tarner IH, Mu¨ller-Ladner U, Uhlemann C, Lange U (2009) The
effect of mild whole-body hyperthermia on systemic levels of
TNF-alpha, IL-1 beta, and IL-6 in patients with ankylosing
spondylitis. Clin Rheumatol 28:397–402
44. Bellometti S, Galzigna L (1998) Serum levels of a prostaglandin
and a leukotriene after termal mud-pack therapy. J Invest Med
46:140–145
45. Ardic¸ F, Ozgen M, Aybek H, Rota S, Cubukc¸u G, Go¨kgo¨z A
(2007) Effect of balneotherapy on serum IL-1, PGE2 and LTB4
levels in fibromyalgia patients. Rheumatol Int 27:441–446
46. Cecchettin M, Bellometti S, Lalli A, Galzigna L (1995) Serum
interleukin 1 changes in arthrosic patients after mud-pack treatment. Phys Rheab Kur Med 5:92–93
47. Bellometti S, Cecchettin M, Galzigna L (1997) Mud-pack therapy
in osteoarthrosis changes levels of chondrocytes markers. Clin
Chim Acta 268:101–106
48. Bellometti S, Galzigna L, Richelmi P, Gregotti C, Berte´ F (2002)
Both serum receptors of tumor necrosis factor are influenced by
mud pack treatment in osteoarthrotic patients. Int J Tissue React
24:57–64
49. Lohmander LS, Hoermer LA, Lark MV (1993) Metalloproteinases, tissue inhibitor, and proteoglycan fragments in kneesynovial
fluid in human osteoarthritis. Arthritis Rheum 36:181–189
50. Malemud CJ, Islam N, Haqqi TM (2003) Pathophysiological
mechanisms in osteoarthritis lead to novel therapeutic strategies.
Cell Tissue Organs 174:34–348
51. Bellometti S, Richelmi P, Tassoni T, Berte` F (2005) Production
of matrix metalloproteinases and their inhibitors in osteoarthritic
patients undergoing mud bath therapy. Int J Clin Pharm Res
25:77–94
52. Trippel SB (1995) Growth factor action on articular cartilage.
J Rheumatol 43:129
53. Shehata M, Schwarzmeier JD, Hilgarth M, Demirtas D, Richter
D, Hubmann R et al (2006) Effect of combined spa-exercise on
circulating TGF-ß1 levels in patients with ankylosing spondylitis.
Wien Klin Wochenschr 118:266–272
54. Centrella M, Horowitz MC, Wozney JM, McCarthy TL (1994)
Transforming growth factor-beta gene family members and bone.
Endocr Rev 15:27–39
55. Shehata M, Schwarzmeier JD, Hilgarth M, Hubmann R, Duechler
M, Gisslinger H (2004) TGF-beta 1 induces bone marrow reticulin fibrosis in hairy cell leukemia. J Clin Invest 113:676–685
56. Farrell AJ, Blake DR, Palmer RM, Moncada S (1992) Increased
concentrations of nitrite in synovial fluid and serum samples
suggest increased nitric oxide synthesis in rheumatic diseases.
Ann Rheum Dis 51:1219–1222
57. Mazzetti I, Grigolo B, Pulsatelli L, Dolzani P, Silvestri T, Roseti
L et al (2001) Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid
arthritis. Clin Science 101:593–599
58. Braga PC, Sambataro G, Dal Sasso M, Culici M, Alfieri M, Nappi
G (2008) Antioxidant effect of sulphurous thermal water on
human neutrophil bursts: chemiluminescence evaluation. Respiration 75:193–201
59. Grabski M, Wozakowska-Kaplon B, Kedziora J (2004) Hydrogen
sulphide water balneum effect on erythrocyte superoxide dismutase activity in patients with rheumatoid arthritis-in vitro
study. Przegl Lek 61:1405–1409
60. Eckmekcioglu C, Strauss-Blasche G, Holzer F, Marktl W (2002)
Effect of sulfur baths on antioxidative defense systems, peroxide
concentrations and lipid levels in patients with degenerative
osteoarthritis. Forsch Komplementarmed Klass Naturheilkd
9:216–220
61. Bender T, Bariska J, Va`ghy R, Gomez R, Kova`cs I (2007) Effect
of balneotherapy on the antoxidant system—a controlled pilot
studyArch Med Res 38:86–89
62. Bellometti S, Poletto M, Gregotti C, Richelmi P, Berte F (2000)
Mud bath therapy influences nitric-oxide, myeloperoxidase and
glutathione peroxidase serum levels in arthritic patients. Int J Clin
Pharmacol Res 20:69–80
63. Fioravanti A, Cantarini L, Bacarelli MR, de Lalla A, Ceccatelli L,
Blardi P (2010) Effects of spa therapy on serum leptin and
adiponectin levels in patients with knee osteoarthritis. Rheumatol
Int [Epub ahead of print]
64. Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P
et al (2003) Evidence for a key role of leptin in osteoarthritis.
Arthritis Rheum 48:3118–3129
65. Lago R, Gomez R, Otero M, Lago F, Gallego R, Dieguez C et al
(2008) A new player in cartilage homeostasis: adiponectin
induces nitric oxide synthase type II and pro-inflammatory
cytokines in chondrocytes. Osteoarthritis Cartilage 16:1101–1109
66. Gomez R, Lago F, Gomez-Reino J, Dieguez C, Gualillo O (2009)
Adipokines in the skeleton: influence on cartilage function and
joint degenerative diseases. J Mol Endocrinol 43:11–18
67. Cozzi F, Carrara M, Sfriso P, Todesco S, Cima L (2004) Antiinflammatory effect of mud-bath applications on adjuvant
arthritis in rats. Clin Exp Rheumatol 22:763–766
68. Britschka ZMN, Teodoro WR, Velosa APP, de Mello SBV
(2007) The effect of Brazilian black mud treatment in chronic
experimental arthritis. Rheumatol Int 28:39–45
69. Mizoguchi T (1970) Effects of thermal spring bath on lipids in
serum. Med Balneol Climat 33:115–120
70. Strauss-Blasche G, Eckmekcioglu C, Leibetseder V, Marktl W
(2003) Seasonal variation of lipid-lowering effects of complex spa
therapy. Forsch Komplementarmed Klass Naturheilkd 10:78–84
71. Bostom AG, Selhub J (1999) Homocysteine and arteriosclerosis:
subclinical and clinical disease associations. Circulation
99:2361–2363
72. Vasan RS, Beiser A, D’Agostino RB, Levy D, Selhub J, Jacques
PF et al (2003) Plasma homocysteine and risk for congestive
heart failure in adult without prior myocardial infarction. JAMA
289:1251–1257
73. Agullo-Ortuno MT, Albaladejo MD, Parra S, Rodrı `guez-Manotas
M, Fenollar M, Ruı `z-Espejo F et al (2002) Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus. Clin Chim Acta; 326:105–112
74. Sun C-F, Haven TR, Wu T-L, Tsao K-C, Wu JT (2002) Serum
total homocysteine increases with the rapid proliferation rate of
tumor cells and decline upon cell death: a potential new tumor
marker. Clin Chim Acta 321:55–62
75. Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L,
Novembrino C et al (2001) Oxidative stress and homocysteine in
coronary artery disease. Clin Chem 471:887–892
76. Leibetseder V, Strauss-Blasche G, Holzer F, Marktl W, Ekmercioglu C (2004) Improving homocysteine levels through balneotherapy: effects of sulphur baths. Clin Chim Acta 343:105–111
77. Ola´h M, Koncz A, Fehe´r J, Ka´lma´nczhey J, Ola´h C, Balogh S
et al (2010) The effect of balneotherapy on C-reactive protein,
serum cholesterol, triglyceride, total antioxidant status and HSP-
60 levels. Int J Biometeorol 54:249–254
78. Turesson C, Jacobsson LTH, Matteson EL (2008) Cardiovascular
co-morbidity in rheumatic diseases. Vasc Health Risk Manag
43:605–614
Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? (pdf)
DownloadCenterforAncientAlchemyandTheHealingArts
Copyright © 2022 CenterforAncientAlchemyandTheHealingArts - All Rights Reserved.
Powered by GoDaddy Website Builder